(Q28325216)

https://api.crossref.org/works/10.1177/106002809102501102

18 November 2022

author name string

L. L. Briceland

1

1 reference

Europe PubMed Central

PubMed ID

1763529

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1763529

18 November 2022

G. R. Bailie

2

1 reference

Europe PubMed Central

PubMed ID

1763529

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1763529

full work available at URL

18 November 2022

language of work or name

English

0 references

publication date

November 1991

0 references

http://journals.sagepub.com/doi/pdf/10.1177/106002809102501102

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

DICP : the annals of pharmacotherapy

18 November 2022

published in

0 references

volume

25

0 references

issue

11

0 references

page(s)

1171-4

0 references

cites work

Recent advances in the diagnosis, treatment, and prevention of Pneumocystis carinii pneumonia

1

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Adverse reactions associated with pentamidine isethionate in AIDS patients: recommendations for monitoring therapy.

18 November 2022

2

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases

18 November 2022

3

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial

18 November 2022

5

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

18 November 2022

6

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

18 November 2022

7

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine

18 November 2022

8

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Pentamidine-associated renal dysfunction and hyperkalemia

18 November 2022

9

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Pentamidine Isethionate in the Treatment of Pneumocystis carinii Pneumonia

18 November 2022

10

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance

18 November 2022

11

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Prediction of creatinine clearance from serum creatinine

18 November 2022

12

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982

18 November 2022

13

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

Pentamidine pharmacokinetics in patients with AIDS with impaired renal function.

18 November 2022

14

1 reference

https://api.crossref.org/works/10.1177/106002809102501102

18 November 2022

Identifiers